[1]
Y. Zhang, Y. Cheng, Y. Guo, R. Hu, and Q. He, “Analysis of the Societal Benefits Derived from Reducing Pharmaceutical Prices based on System Dynamics”, TEBMR, vol. 7, pp. 85–92, Jun. 2024, doi: 10.62051/z7gx6c77.